Revisiting TLR9 as a target for CLL therapy

Blood. 2021 Jun 3;137(22):3006-3008. doi: 10.1182/blood.2020010618.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • B-Lymphocytes
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Oligodeoxyribonucleotides
  • Toll-Like Receptor 9* / genetics

Substances

  • Oligodeoxyribonucleotides
  • TLR9 protein, human
  • Toll-Like Receptor 9